"Research chemicals": Tryptamine and phenethylamine use among high-risk youth

Substance Use and Misuse

Volumn 43, Issue 3-4, 2008, Pages 389-402

  Sanders, Bill ^a,b,c   Lankenau, Stephen E ^a,b   Bloom, Jennifer Jackson ^b   Hathazi, Dodi ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Hallucinogen; High risk youth; Injection drug user; Phenethylamine; Tryptamine

Indexed keywords

KETAMINE; PHENETHYLAMINE; TRYPTAMINE;

ADOLESCENT; ADULT; ARTICLE; COMMUNITY SAMPLE; DIARRHEA; DISORIENTATION; DRUG USE; FEMALE; HALLUCINATION; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; INJECTION; INTERNET; INTERVIEW; JUVENILE; MAJOR CLINICAL STUDY; MALE; MUSIC; NAUSEA; PRIORITY JOURNAL; UNITED STATES; VOMITING;

ADOLESCENT; ADULT; CALIFORNIA; CATCHMENT AREA (HEALTH); CONFUSION; CROSS-SECTIONAL STUDIES; DIARRHEA; FEMALE; HALLUCINATIONS; HEALTH STATUS; HUMANS; INTERVIEW, PSYCHOLOGICAL; KETAMINE; MALE; NAUSEA; PHENETHYLAMINES; PSYCHOTROPIC DRUGS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; TRYPTAMINES; VOMITING;

EID: 41349083385     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/00952990701202970     Document Type: Article

References (42)

1. Australian Bureau of Criminal Intelligence (ABCI). (2002). Australian Illicit Drug Report 2000-01. Canberra: Commonwealth of Australia.
2. Biernacki, P., Waldorf, D. (1981). Snowball: Problems and techniques of chain referral sampling. Sociological Methods and Research 10:141-163.
3. Carmo, H., Hengstler, J. G., de Boer, D., Ringel, M., Remiao, F., Carvalho, F., et al. (2005). Metabolic pathways of 4-bromo-2,5- dimethoxyphenethylamine (2C-B): Analysis of phase I metabolism with hepatocytes of six species including human. Toxicology 206(1):75-89.
4. Check, E. (2004). The ups and downs of ecstasy. Nature 429:126-128.
5. Clatts, M. C., Rees Davis, W., Atillasoy, A. (1995). Hitting a moving target: The use of ethnographic methods in the development of sampling strategies for the evaluation of AIDS outreach programs for homeless youth in New York City. In E. Lambert (Ed.), The collection and interpretation of data from hidden populations (NIDA Research Monograph 98). Rockville, MD: US Department of Health and Human Services.
6. Des Jarlais, D., Perlis, T., Settembrino, J. (2005). The use of electronic debit cards in longitudinal data collection with geographically mobile drug users. Drug and Alcohol Dependence 77(1):1-5.
7. Drug Enforcement Administration. (2003). Microgram Bulletin 36(5). Washington, DC: Author.
8. Drug Enforcement Administration. (2005). Microgram Bulletin 38(3). Washington, DC: Author.
9. Griffiths, R. R., Richards, W. A., McCann, U., Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance [Electronic version]. Psychopharmacology 187:268-283.
10. Halpern, J. H. (2004). Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology Therapeutics 102(2):131-138.
11. Halpern, J. H., Pope, H. G., Jr. (1999). Do hallucinogens cause residual neuropsychological toxicity? Drug and Alcohol Dependence 53(3):247-256.
12. Halpern, J. H., Pope, H. G., Jr. (2001). Hallucinogens on the Internet: A vast new source of underground drug information. American Journal of Psychiatry 158(3):481-483.
13. Hathazi, D., Lankenau, S. E., Sanders, B., Jackson-Bloom, J. (2005, December). The Normalization of polydrug use amongst homeless traveler youth. Paper presented at the American Public Health Association 133rd Annual Meeting, Philadelphia.
14. Hyde, J. (2005). From home to street: Understanding young people's transitions into homelessness. Journal of Adolescence 28(2):171-183.
15. Jacob, M. S., Presti, D. E. (2005). Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. Medical Hypotheses 64(5):930-937.
16. Jansen, K. L. R. (2001). Ketamine: Dreams and realities. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies.
17. Kalant, H. (2001). The pharmacology and toxicology of "ecstasy": (MDMA) and related drugs. Canadian Medical Association Journal 165(7):917-928.
18. Kikura-Hanajiri, R., Hayashi, M., Saisho, K., Goda, Y. (2005). Simultaneous determination of nineteen hallucinogenic tryptamines/beta- calbolines and phenethylamines using gas chromatography-mass spectrometry and liquid chromatography-electrospray ionisation-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 825(1):29-37.
19. Laks, S., Pelander, A., Vuori, E., Ali-Tolppa, E., Sippola, E., Ojanpera, I. (2004). Analysis of street drugs in seized material without primary reference standards. Analytical Chemistry 76(24):7375-7379.
20. Lankenau, S. E. (2006). On ketamine: In and out of the K hole. In B. Sanders (Ed.), Drugs, clubs and young people: Sociological and public health perspective. Aldershot, UK: Ashgate.
21. Lankenau, S. E., Clatts, M. C. (2005). Patterns of polydrug use among ketamine injectors in New York City. Substance Use Misuse 40:1381-1397.
22. Lankenau, S. E., Sanders, B. (2007). Patterns and frequencies of ketamine use in New York City. Journal of Psychoactive Drugs.
23. Lankenau, S. E., Sanders, B., Jackson-Bloom, J., Hathazi, S., Alarcon, E., Tortus, S., Clatts, M. (2007). Ketamine injection initiation among young injection drug users (IDUs) in three U.S. cities. Drug and Alcohol Dependence 87:183-193.
24. McCandless, D. (2004, February 16). Goodbye ecstasy, hello 5-Meo-DMT: New designer drugs are just a click away. The Guardian (Electronic Version) Available from http://www:guardian.co.uk
25. McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology and Therapeutics 102(2):111-129.
26. Measham, F. (2004). Play space: Historical and socio-cultural reflections on drugs, licensed leisure locations, commercialization and control. International Journal of Drug Policy 15:337-345.
27. Muller, A. A. (2004). New drugs of abuse update: Foxy methoxy. Journal of Emergency Nursing 30(5):507-508.
28. Nichols, D. E. (2004). Hallucinogens. Pharmacology and Therapeutics, 101, 131-181.
29. Penrod, J., Preston, D. B., Cain, R. E., Starks, M. (2003). A discussion of chain referral as a method for sampling hard-to-reach populations. Journal of Transcultural Nursing 14:100-107.
30. Rushkoff, D. (1994). Cyberia: Life in the trenches of hyperspace. Manchester, UK: Clinamen Press.
31. Sanders, B. (2006). Young people, clubs and drugs. In B. Sanders (Ed.), Drugs, clubs and young people: Sociological and public health perspectives pp. 1-12. Aldershot, UK: Ashgate.
32. Sewell, R. A., Halpern, J. H., Pope, H. G., Jr. (2006). Response of cluster headache to psilocybin and LSD. Neurology 66(12):1920-1922.
33. Sessa, B. (2005). Can psychedelics have a role in psychiatry once again? British Journal of Psychiatry 186:457-458.
34. Shulgin, A., Shulgin, A. (1991). PiHKAL (phenethylamines I have known and loved). Berkeley: Transform Press.
35. Shulgin, A., Shulgin, A. (1997). TiHKAL (tryptamines I have known and loved): The continuation. Berkeley: Transform Press.
36. Tanaka, E., Kamata, T., Katagi, M., Tsuchihashi, H., Honda, K. (2006). A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy [Electronic version]. Forensic Science International 163:152-154.
37. Vastag, B. (2005). Addiction research: Ibogaine therapy: A "vast, uncontrolled experiment." Science 308(5720):345-346.
38. Watters, J. K., Biernacki, P. (1989). Targeted sampling: Options and considerations for the study of hidden populations. Social Problems 36:416-430.
39. Wilson, J. M., McGeorge, F., Smolinske, S., Meatherall, R. (2005). A foxy intoxication. Forensic Science International 148(1):31-36.
40. Winstock, A. R., Wolff, K., Ramsey, J. (2001). Ecstasy pill testing: harm minimization gone too far? Addiction 96(8):1139-1148.
41. Yacoubian, G. S., Jr., Miller, S., Pianim, S., Kunz, M., Orrick, E., Link, T., et al. (2004). Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees. Journal of Drug Education 34(1):41-59.
42. Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. New Haven: Yale University Press.